These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 26063045)

  • 1. In Vitro and In Vivo Efficacy of Self-Assembling RGD Peptide Amphiphiles for Targeted Delivery of Paclitaxel.
    Saraf P; Li X; Wrischnik L; Jasti B
    Pharm Res; 2015 Sep; 32(9):3087-101. PubMed ID: 26063045
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fatty acid-RGD peptide amphiphile micelles as potential paclitaxel delivery carriers to α(v)β₃ integrin overexpressing tumors.
    Javali NM; Raj A; Saraf P; Li X; Jasti B
    Pharm Res; 2012 Dec; 29(12):3347-61. PubMed ID: 22825750
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Binding and uptake of novel RGD micelles to the αvβ3 integrin receptor for targeted drug delivery.
    Raj A; Saraf P; Javali NM; Li X; Jasti B
    J Drug Target; 2014 Jul; 22(6):518-27. PubMed ID: 24611965
    [TBL] [Abstract][Full Text] [Related]  

  • 4. RGD-modified polymeric micelles as potential carriers for targeted delivery to integrin-overexpressing tumor vasculature and tumor cells.
    Wang Y; Wang X; Zhang Y; Yang S; Wang J; Zhang X; Zhang Q
    J Drug Target; 2009 Jul; 17(6):459-67. PubMed ID: 19527117
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cyclic RGD conjugated poly(ethylene glycol)-co-poly(lactic acid) micelle enhances paclitaxel anti-glioblastoma effect.
    Zhan C; Gu B; Xie C; Li J; Liu Y; Lu W
    J Control Release; 2010 Apr; 143(1):136-42. PubMed ID: 20056123
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Arg-Gly-Asp (RGD) peptide conjugated poly(lactic acid)-poly(ethylene oxide) micelle for targeted drug delivery.
    Hu Z; Luo F; Pan Y; Hou C; Ren L; Chen J; Wang J; Zhang Y
    J Biomed Mater Res A; 2008 Jun; 85(3):797-807. PubMed ID: 17896765
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synthesis and characterization of RGD-fatty acid amphiphilic micelles as targeted delivery carriers for anticancer agents.
    Shen SI; Kotamraj PR; Bhattacharya S; Li X; Jasti BR
    J Drug Target; 2007 Jan; 15(1):51-8. PubMed ID: 17365273
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cyclic RGDyK conjugation facilitates intracellular drug delivery of polymeric micelles to integrin-overexpressing tumor cells and neovasculature.
    Yin J; Li Z; Yang T; Wang J; Zhang X; Zhang Q
    J Drug Target; 2011 Jan; 19(1):25-36. PubMed ID: 20233083
    [TBL] [Abstract][Full Text] [Related]  

  • 9. RGD peptide-decorated micelles assembled from polymer-paclitaxel conjugates towards gastric cancer therapy.
    Shi J; Liu S; Yu Y; He C; Tan L; Shen YM
    Colloids Surf B Biointerfaces; 2019 Aug; 180():58-67. PubMed ID: 31028965
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Targeting of tumor endothelium by RGD-grafted PLGA-nanoparticles loaded with paclitaxel.
    Danhier F; Vroman B; Lecouturier N; Crokart N; Pourcelle V; Freichels H; Jérôme C; Marchand-Brynaert J; Feron O; Préat V
    J Control Release; 2009 Dec; 140(2):166-73. PubMed ID: 19699245
    [TBL] [Abstract][Full Text] [Related]  

  • 11. RGD peptide-modified multifunctional dendrimer platform for drug encapsulation and targeted inhibition of cancer cells.
    He X; Alves CS; Oliveira N; Rodrigues J; Zhu J; Bányai I; Tomás H; Shi X
    Colloids Surf B Biointerfaces; 2015 Jan; 125():82-9. PubMed ID: 25437067
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hydrophobically modified inulin as an amphiphilic carbohydrate polymer for micellar delivery of paclitaxel for intravenous route.
    Muley P; Kumar S; El Kourati F; Kesharwani SS; Tummala H
    Int J Pharm; 2016 Mar; 500(1-2):32-41. PubMed ID: 26792170
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthesis and biological evaluation (in vitro and in vivo) of cyclic arginine-glycine-aspartate (RGD) peptidomimetic-paclitaxel conjugates targeting integrin αVβ3.
    Colombo R; Mingozzi M; Belvisi L; Arosio D; Piarulli U; Carenini N; Perego P; Zaffaroni N; De Cesare M; Castiglioni V; Scanziani E; Gennari C
    J Med Chem; 2012 Dec; 55(23):10460-74. PubMed ID: 23140358
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Folate and CD44 receptors dual-targeting hydrophobized hyaluronic acid paclitaxel-loaded polymeric micelles for overcoming multidrug resistance and improving tumor distribution.
    Liu Y; Sun J; Lian H; Cao W; Wang Y; He Z
    J Pharm Sci; 2014 May; 103(5):1538-47. PubMed ID: 24619562
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Thermoresponsive nanostructured polycarbonate block copolymers as biodegradable therapeutic delivery carriers.
    Kim SH; Tan JP; Fukushima K; Nederberg F; Yang YY; Waymouth RM; Hedrick JL
    Biomaterials; 2011 Aug; 32(23):5505-14. PubMed ID: 21529935
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Redox-sensitive micelles self-assembled from amphiphilic hyaluronic acid-deoxycholic acid conjugates for targeted intracellular delivery of paclitaxel.
    Li J; Huo M; Wang J; Zhou J; Mohammad JM; Zhang Y; Zhu Q; Waddad AY; Zhang Q
    Biomaterials; 2012 Mar; 33(7):2310-20. PubMed ID: 22166223
    [TBL] [Abstract][Full Text] [Related]  

  • 17. c(RGDyK)-decorated Pluronic micelles for enhanced doxorubicin and paclitaxel delivery to brain glioma.
    Huang Y; Liu W; Gao F; Fang X; Chen Y
    Int J Nanomedicine; 2016; 11():1629-41. PubMed ID: 27143884
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synthesis and biological evaluation of dimeric RGD peptide-paclitaxel conjugate as a model for integrin-targeted drug delivery.
    Chen X; Plasencia C; Hou Y; Neamati N
    J Med Chem; 2005 Feb; 48(4):1098-106. PubMed ID: 15715477
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Endosomal pH-Responsive Polymer-Based Dual-Ligand-Modified Micellar Nanoparticles for Tumor Targeted Delivery and Facilitated Intracellular Release of Paclitaxel.
    Gao Y; Zhang C; Zhou Y; Li J; Zhao L; Li Y; Liu Y; Li X
    Pharm Res; 2015 Aug; 32(8):2649-62. PubMed ID: 25676595
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Toward the development of a novel non-RGD cyclic peptide drug conjugate for treatment of human metastatic melanoma.
    Redko B; Tuchinsky H; Segal T; Tobi D; Luboshits G; Ashur-Fabian O; Pinhasov A; Gerlitz G; Gellerman G
    Oncotarget; 2017 Jan; 8(1):757-768. PubMed ID: 27768593
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.